BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37704056)

  • 1. Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models.
    Tang J; Kang Y; Zhou Y; Chen Q; Lan J; Liu X; Peng Y
    Brain Res Bull; 2023 Oct; 202():110760. PubMed ID: 37704056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.
    Sun H; Bénardais K; Stanslowsky N; Thau-Habermann N; Hensel N; Huang D; Claus P; Dengler R; Stangel M; Petri S
    PLoS One; 2013; 8(9):e72926. PubMed ID: 24069165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cellular Model of Amyotrophic Lateral Sclerosis to Study the Therapeutic Effects of Extracellular Vesicles from Adipose Mesenchymal Stem Cells on Microglial Activation.
    Dabrowska S; Turano E; Scambi I; Virla F; Nodari A; Pezzini F; Galiè M; Bonetti B; Mariotti R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Inflammatory Effects of Miyako
    Tsuruta K; Shidara T; Miyagishi H; Nango H; Nakatani Y; Suzuki N; Amano T; Suzuki T; Kosuge Y
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
    Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
    CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS.
    Provenzano F; Nyberg S; Giunti D; Torazza C; Parodi B; Bonifacino T; Usai C; Kerlero de Rosbo N; Milanese M; Uccelli A; Shaw PJ; Ferraiuolo L; Bonanno G
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BCL-2 family protein Bid is critical for pro-inflammatory signaling in astrocytes.
    König HG; Coughlan KS; Kinsella S; Breen BA; Prehn JH
    Neurobiol Dis; 2014 Oct; 70():99-107. PubMed ID: 24956542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside-Rg1 combined with a conditioned medium from induced neuron-like hUCMSCs alleviated the apoptosis in a cell model of ALS through regulating the NF-κB/Bcl-2 pathway.
    Huang Y; Yang H; Yang B; Zheng Y; Hou X; Chen G; Zhang W; Zeng X; DU B
    Chin J Nat Med; 2023 Jul; 21(7):540-550. PubMed ID: 37517821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
    Uccelli A; Milanese M; Principato MC; Morando S; Bonifacino T; Vergani L; Giunti D; Voci A; Carminati E; Giribaldi F; Caponnetto C; Bonanno G
    Mol Med; 2012 Jul; 18(1):794-804. PubMed ID: 22481270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Increase in Peroxiredoxin 6 Expression Induces Neurotoxic A1 Astrocytes in the Lumbar Spinal Cord of Amyotrophic Lateral Sclerosis Mice Model.
    Yamamuro-Tanabe A; Mukai Y; Kojima W; Zheng S; Matsumoto N; Takada S; Mizuhara M; Kosuge Y; Ishimaru Y; Yoshioka Y
    Neurochem Res; 2023 Dec; 48(12):3571-3584. PubMed ID: 37556038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
    Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
    Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model.
    Post J; Kogel V; Schaffrath A; Lohmann P; Shah NJ; Langen KJ; Willbold D; Willuweit A; Kutzsche J
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33805709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis.
    Korhonen P; Pollari E; Kanninen KM; Savchenko E; Lehtonen Š; Wojciechowski S; Pomeshchik Y; Van Den Bosch L; Goldsteins G; Koistinaho J; Malm T
    IBRO Rep; 2019 Jun; 6():74-86. PubMed ID: 30705990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.